ReviewThe Milbank quarterly2005
Pharmacy utilization and the Medicare Modernization Act.
Review in The Milbank quarterly, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.BMC health services research · 2022Pooled it
- Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.The Cochrane database of systematic reviews · 2014Pooled it
- Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation.PloS one · 2024Article
- Respiratory questionnaire-based analysis of awareness of COPD in a large multicenter rural population-based study in India.Chronic diseases and translational medicine · 2022Article
- Whom do older adults trust most to provide information about prescription drugs?The American journal of geriatric pharmacotherapy · 2009Article
- Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.Health services research · 2008Article
- What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.International journal for equity in health · 2008Article
- Medication adherence issues in patients treated for COPD.International journal of chronic obstructive pulmonary disease · 2008Review
- Coverage of atypical antipsychotics among medicare drug plans in the state of washington for fiscal year 2007.Primary care companion to the Journal of clinical psychiatry · 2008Article
- Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.The Milbank quarterly · 2007Article
- Drug insurance utilization management policies and "reference pricing": an illustrated commentary on the article by Vittorio Maio and colleagues.The Milbank quarterly · 2005Review
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To control expenditures and use medications appropriately, the Medicare drug coverage program has established pharmacy utilization management (PUM) measures. This article assesses the effects of these strategies on the care of seniors. The literature suggests that although caps on drug benefits lower pharmaceutical costs, they may also increase the use of other health care services and hurt health outcomes. Our review raises concerns regarding the potential unintended effects of the Medicare drug program's PUM policies for beneficiaries. Therefore, the economic and clinical impact of PUM measures on seniors should be studied further to help policymakers design better drug benefit plans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.